Sorry, you need to enable JavaScript to visit this website.

Posters and Publications

Publications and Presentations

AMP 2012 Poster Presentations
Sunday, January 1, 2012

Diagnostic Role of a SNP Microarray in the Evaluation of Patients with Myelodysplastic Syndrome (MDS) - Schwartz, S., Thomason, R., Tepperberg J., Papenhausen, P., Anderson, S.

NSCLC Patients with an Isolated 5' Green Signal Pattern in ALK FISH Testing May Be Positive for Complex EML4-ALK Rearrangement with 3' Deletion and May Benefit from Crizotinib Targeted Therapy - Guoxian Sun, Shelly Woo, Lya Montella, Lukasz Kozon, Hongyan Xie, and Anthony Dilig

SABCS 2012 Poster Presentations:
Sunday, January 1, 2012

Quantitative Measurement of HER2 Expression in Breast Cancers: Comparison with “Real World” HER2 Testing in a Multi-Center Collaborative Biomarker Study (CBS) and Correlation with Clinicopathological Features - D Yardley, P Kaufman, J Adams, L Krekow, M Savin, W. Lawler, S Zrada, A Starr, H Einhorn, L Schwartzberg, W Huang, J Weidler, Y Lie, A Paquet, M Haddad, J Sperinde, S Anderson, M Brigino, L Blosserman 

Correlation of Quantitative p95HER2 and Total HER2 Levels with Clinical Outcomes in a Combined Analysis of Two Cohorts of Trastuzumab-Treated Metastatic Breast Cancer Patients - R Duchnowska, J Sperinde, K Leitzel, B Szostakiewicz, A Paquet, SM Ali, T Jankowski, M Haddad, E Fuchs, B Artukowicz-Czartoryska, J Winslow, C F Singer, PJ Wysocki, Y Lie, R Hovart, M Foszczynska-Ktoda, C Petropoulos, B Radecka, MM Litwiniuk, S Debska, J Weidler, W Huang, W Biernat, WJ Kostler, J Jassem, A Lipton

Quantitative HER3 Protein Expression and PIK3CA Mutation Status in Matched Samples from Primary and Metastatic Breast Cancer Tissues and Correlation with Time to Recurrence - J Sperinde, J Lara, R Michaelson, X Sun, P Conte, V Guameri, E Barbieri, SM Ali, K Leitzel, J Weidler, Y Lie, J Cook, M Haddad, A Paquet, J Winslow, J Howitt, L Hurley, M Eisenberg, C Petropoulos, W Huang, A Lipton

CAP 2013 Poster Presentations
Tuesday, January 1, 2013

Quantitative Measurement of HER2 Expression in Breast Cancers: Comparison with “Real World” HER2 Testing in a Multi-Center Collaborative Biomarker Study (CBS) and Correlation with Clinicopathological Features - Augusto F.G. Paulino, M.D.